Cathepsin K in treatment monitoring following intravenous zoledronic acid.

Jahn, Oliver; Wex, Thomas; Klose, Silke; Kropf, Siegfried; Adolf, Daniela; Piatek, Stefan

Jahn, Oliver; Wex, Thomas; Klose, Silke; Kropf, Siegfried; Adolf, Daniela; Piatek, Stefan.

Afiliación

Jahn O; Department of Trauma Surgery, Otto von Guericke University, D-39120 Magdeburg, Germany.
Wex T; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, D-39120 Magdeburg, Germany ; Medical Laboratory for Clinical Chemistry, Microbiology and Infectious Diseases, Department Molecular Genetics, Otto von Guericke University, D-39124 Magdeburg, Germany.
Klose S; Department of Nephrology, Hypertension, Endocrinology and Metabolic Diseases, Otto von Guericke University, D-39120 Magdeburg, Germany.
Kropf S; Department of Biometry and Medical Informatics, Otto von Guericke University, D-39120 Magdeburg, Germany.
Adolf D; Department of Biometry and Medical Informatics, Otto von Guericke University, D-39120 Magdeburg, Germany.
Piatek S; Department of Trauma Surgery, Otto von Guericke University, D-39120 Magdeburg, Germany.

Biomed Rep ; 2(6): 915-917, 2014 Nov.

Article en En | MEDLINE | ID: mdl-25279169

Palabras clave

bisphosphonat; bone density measurement; cathepsin K; compliance; osteoporosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomed Rep Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google